Impact of neuroendocrine activation on coronary artery disease

American Journal of Cardiology

Volumn 82, Issue 3 A, 1998, Pages 8-14

  Swedberg, Karl B ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; CELL INTERACTION; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN CELL; HUMAN TISSUE; PREDICTION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

ANGIOTENSIN;

EID: 0031722961     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00485-8     Document Type: Article

References (30)

1. Inkeles S., Eisenberg D. Hyperlipidemia and coronary atherosclerosis a review . Medicine. 70:1981;110-123.
2. The Lipid Research Clinics Coronary Primary Prevention Trial Results II. Reduction in incidence of coronary heart disease . JAMA. 251:1984;351-364.
3. The Lipid Research Clinics Coronary Primary Prevention Trial Results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering . JAMA. 251:1984;365-374.
4. Smoking and Health, Ch 3: Criteria for Judgement. DHEW Publication No. (NIH) 1103, Washington DC, US Government Printing Office, 1964.
5. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events Final report of the pooling project . J Chronic Dis. 31:1978;201-306.
6. Oberman A., Harlan W.R., Smith M., Graybiel A. The cardiovascular risk associated with different levels and types of elevated blood pressure. Minn Med. 52:1969;1283-1288.
7. Arch Intern Med. 148:1988;1023-1038.
8. Ross R., Fuster V. The treatment of atherosclerosis. Ross R., Topol E.J. Atherosclerosis and Coronary Artery Disease. 1996;441-462 Lippincott-Raven, Philadelphia.
9. DiCorleto P.E., Soyombo A.A. The role of the endothelium in atherogenesis. Curr Opin Lipidol. 4:1993;364-372.
10. Davies P.F., Tripathi S.C. Mechanical stress mechanisms and the cell an endothelial paradigm (Mini review) . Circ Res. 72:1993;239-244.
11. Etingen O.R., Silverstein R.L., Friedman H.M., Hajjar D.P. Viral activation of the coagulation cascade molecular interactions at the surface of infected endothelial cells . Cell. 61:1990;657-662.
12. Etingin O.R., Silverstein R.L., Hajjar D.P. Identification of a monocyte receptor on herpes virus-infected endothelial cells. Proc Natl Acad Sci USA. 88:1991;7200-7203.
13. Berliner J.A., Haberland M.E. Role of oxidized low density lipoprotein in atherogenesis. Curr Opin Lipidol. 4:1993;373-381.
14. Chisolm G.M. The oxidation of lipoproteins implications for atherosclerosis . Spatz L., Bloom A.D. Mechanisms and Consequences of Oxidative Damage. 1992;78-106 Oxford University Press, Oxford.
15. Pober J.S., Cotran R.C. Cytokines and endothelial cell biology. Physiol Rev. 70:1990;427-451.
16. Murphy-Chutorian D., Alderman E.L. The case that hyperhomocysteinemia is a risk factor for coronary artery disease. Am J Cardiol. 73:1994;705-707.
17. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
18. Swedberg K., Eneroth P., Kjekhus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 82:1990;1730-1736.
19. DiCorleto P.E., Gimbrone M.A. Vascular endothelium. Fuster V., Ross R., Topol E.J. Atherosclerosis and Coronary Artery Disease. 1996;387-399 Lippincott-Raven, Philadelphia.
20. Weber K.T., Anversa P., Armstrong P.W., Brilla C.G., Burnett J.C. Jr, Cruickshank J.M., Devereux R.B., Giles T.D., Korsgaard N., Leier C.V., et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 20:1992;3-16.
21. Dzau V.J. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Basic Res Cardiol. 88:(suppl 1):1993;1-14.
22. Lüscher T.F., Noll G. The endothelium in coronary vascular control. Braunwald E. Heart Disease - Update. 1995;1165 WB Saunders, Philadelphia.
23. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
24. Levin E.R. Endothelins. N Engl J Med. 333:1995;356-363.
25. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
26. Lerman A., Holmes D.R. Jr, Bell M.R., Garratt K.N., Nishimura R.A., Burnett J.C. Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 92:1995;2426-2431.
27. Zeiher A.M., Goebel H., Schachinger V., Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 91:1995;941-947.
28. Pousset F., Isnard R., Lechat P., Kalotka H., Carayon A., Maistre G., Escolano S., Thomas D., Komajda M. Prognostic value of endothelin-1 in chronic heart failure. (Abstr.). Circulation. 94:(suppl 1):1996;494.
29. Fujisaki H., Ito H., Hirata Y., Tanaka M., Hata M., Lin M., Adachi S., Akimoto H., Marumo F., Hiroe M. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest. 96:1995;1059-1065.
30. Clavell A.L., Mattingly M.T., Stevens T.L., Nir A., Wright S., Aarhus L.L., Heublein D.M., Burnett J.C. Jr. Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction. J Clin Invest. 97:1996;1286-1292.